Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 14/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8777892 | 0.86 | EPHX2 (0.48) | MAPTNPSR1EPHX2 | |
| SCHEMBL8777901 | 0.84 | EPHX2 (0.52) | MAPTNPSR1EPHX2 | |
| SCHEMBL8777963 | 0.80 | EPHX2 (0.47) | MAPTNPSR1EPHX2 | |
| SCHEMBL8777850 | 0.79 | HSD11B1 (0.38) | MAPTNPSR1EPHX2 | |
| SCHEMBL4348756 | 0.74 | NPSR1 (0.55) | MAPTNPSR1EPHX2 | |
| SCHEMBL8803890 | 0.72 | EPHX2 (0.54) | MAPTNPSR1EPHX2 | |
| SCHEMBL8803889 | 0.72 | EPHX2 (0.54) | MAPTNPSR1EPHX2 | |
| SCHEMBL8804609 | 0.72 | EPHX2 (0.54) | EPHX2 | |
| SCHEMBL4346873 | 0.72 | EPHX2 (0.57) | MAPTNPSR1EPHX2 | |
| SCHEMBL8778024 | 0.71 | EPHX2 (0.46) | MAPTEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0665216-B1 | Urea derivatives and their use as acat inhibitors | NISSHIN FLOUR MILLING CO (JP) | 1997-12-29 | — | — | EP | disclosed |
| US-5576335-A | TREATMENT OF HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1996-11-19 | — | — | US | disclosed |
| EP-0665216-A1 | Urea derivatives and their use as acat inhibitors | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1995-08-02 | — | — | EP | disclosed |